Skip to main content
. 2022 Jun 23;12:893424. doi: 10.3389/fonc.2022.893424

Figure 2.

Figure 2

Significant survival differences for model _3 and five external validation sets. Relapse-related deep-features of model_3 were used for subgrouping, and KM plot was used to show the difference in relapse levels between the two subgroups. The Lasso model constructed according to model_3 was validated in each of the five external validation sets. (A) KM plot of model_3 (log-rank P-value = 6e-09, the time of half relapse is about 3.5 years). (B) GSE70768 validation set (mRNA, Number of samples = 111, log-rank p-value = 4.46e-07). (C) GSE26367 validation set (miRNA, N = 149, log-rank P-value = 0.000319447). (D) GSE26126 validation set (DNA methylation, N = 85, log-rank P-value = 0.003265681). (E) GSE21035 validation set (CNVs, N = 198, log-rank P-value = 0), and (F) Re-annotated GSE70768 validation set (mRNA, N = 111, log-rank P-value = 0.017250485).